Skip to main content
. 2024 Dec 30;19:182. doi: 10.1186/s13014-024-02573-9

Table 1.

Patient characteristics

Gender
Male 54 (42%)
Female 75 (58%)
Extracranial tumor activity
 Yes 39
 No 90
Diagnosis of brain metastases within 30 days after diagnosis of primary tumor
 Yes 39
 No 90
Prior brain treatment
 Yes 23
 No 106
Prior SRS
 Yes 15
 No 114
Prior WBRT
 Yes 7
 No 122
Prior surgery
 Yes 8
 No 121
Prior systemic treatment
 Yes 76
 No 53
Presence of extracranial metastases
 Yes 54
 No 75
Presence of lymph node metastases
 Yes 68
 No 61
Presence of seizure
 Yes 18
 No 111
KPS score
 60 3
 70 14
 80 31
 90 38
 100 43
Occurrence of new metastases after GKRS
 Yes 62
 No 67
Presence of local recurrence
 Yes 40
 No 89
Total tumor volume (mm3)
 Average 17,445 (88–88,029 mm3)
Treatment dose (Gy)
 Average (minimum–maximum) 22 (18–25)
Age at diagnosis of brain metastases (years)
 Average (minimum–maximum) 63 (36–85)
Primary tumor type
 Lung 89
 Melanoma 8
 Breast 3
 Others 29
Number of brain metastases
 1 30
 2–3 50
 4–10 41
 > 10 8